| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $769.0M | +3.2% | +22.9% |
| Cost of Revenue | $252.5M | +1.5% | -6.6% |
| R&D Expense | $38.1M | -4.7% | +7.6% |
| SG&A Expense | $313.6M | +3.3% | +30.3% |
| Operating Income | $137.4M | +80.5% | +185.6% |
| Pre-tax Income | $144.0M | -23.5% | +152.5% |
| Income Tax | $25.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $18.8M | — | -73.9% |
| Accounts Receivable | $619.1M | +1.2% | +5.3% |
| Inventory | $771.5M | -0.1% | +7.5% |
| Current Assets | $1.92B | +11.2% | -6.4% |
| Total Assets | $5.10B | +2.7% | +0.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $504.9M | — | — |
| Capital Expenditures | $118.5M | — | — |
| Investing Cash Flow | -$243.6M | — | — |
| Financing Cash Flow | -$692.4M | — | — |
| Free Cash Flow | $386.4M | — | — |
| +270.6% |
| +381.7% |
| Net Income | $119.0M | -41.4% | +129.5% |
| EPS (Basic) | $0.88 | -41.3% | +131.6% |
| EPS (Diluted) | $0.88 | -40.9% | +131.6% |
| $466.0M |
| +9.7% |
| -43.0% |
| Total Liabilities | $696.8M | +4.7% | -31.5% |
| Stockholders' Equity | $4.40B | +2.4% | +8.1% |